Review
Copyright ©The Author(s) 2015.
World J Ophthalmol. Feb 12, 2015; 5(1): 1-15
Published online Feb 12, 2015. doi: 10.5318/wjo.v5.i1.1
Table 4 Overview of mucous membrane pemphigoid and pseudopemphigoid as caused by the pemphigus disease
MMPPseudopemphigoid
PNPOPV
LocationSubepidermalIntraepidermalIntraepidermal
DIFIgG/IgA/IgM/C3IgG/C3IgG/C3
IIF on salt-split skinDermal, epidermal, or combined depending on antigenNot applicableNot applicable
IEM: ultrastructural location of antigenLamina lucidaHemidesmosomesDesmosomes
Lamina densaDesmosomal plaques
Sublamina densa (anchoring fibrils)Lamina lucida
Immunoblot: determination of antigenBullous pemphigoid antigen 1 (Bullous Pemphigoid 230) Bullous pemphigoid antigen 2 (Bullous Pemphigoid 180, type XVII collagen) Type VII collagen (290 kDa) Laminin332, epiligrin, or laminin 5 α3β3γ2 (165, 145, 140, 105 kDa) Laminin 6 (α3) Integrin beta 4 45 kDa epithelial protein 130 kDa epithelial protein 140 kDa epithelial protein 205 kDa epithelial protein 168 kDa epithelial protein Uncein LAD-1 (97/120 kDa)Plakin protein family: Desmoplakin I (250 kDa) Bullous pemphigoid antigen 1 (230 kDa) Desmoplakin II and envoplakin (210 kDa) Periplakin (190 kDa) Plectin (500 kDa) Desmocollin 2 (105 kDa) Desmocollin 3 α2-macroglobulin-like-1 (A2LM1, 170 kDa) Desmoglein 1 (160 kDa) Desmoglein 3 (130 kDa)Desmoglein 1 (160 kDa) Desmoglein 3 (130 kDa)
Increased malignancyYes - solid malignancies (laminin 332 subtype)Yes - lymphoproliferative malignancies--